StockSelector.com
  Research, Select, & Monitor Saturday, November 17, 2018 3:01:19 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Proteostasis Therapeutics, Inc.$6.14($.09)(1.44%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Proteostasis Therapeutics, Inc. has an overall rank of 6997 out of 7183 stocks based on 4 positive rankings and 9 negative rankings.

Positive Rankings
90 Day Gain
Proteostasis Therapeutics rank is 63
Low vPut/Call
Proteostasis Therapeutics has a low Put/Call ratio of 0.18 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Proteostasis Therapeutics is ranked 371.
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Proteostasis Therapeutics is ranked 615.
Debt-to-Equity
Proteostasis Therapeutics rank is 831
Negative Rankings
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Proteostasis Therapeutics is ranked 159.
Negative Net Margin
Proteostasis Therapeutics rank is 163
Price-to-Sales
Proteostasis Therapeutics rank is 165
Down EPS Surprise
Proteostasis Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
Negative ROE
Proteostasis Therapeutics rank is 393
Negative ROA
Proteostasis Therapeutics rank is 437
10 Day Loss
Proteostasis Therapeutics rank is 629
High Put/Call
Proteostasis Therapeutics has a high Put/Call ratio of 0.74 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Proteostasis Therapeutics is ranked 1375.
Price-to-Book
Proteostasis Therapeutics rank is 1588







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.